← SynDRA
EPIANDROSTERONE
SynDRA canonical compound SYN0009301 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
|---|
| Primary target(s) | G6PD |
|---|
| Mechanism of action | steroid |
|---|
All known targets
Mechanisms of action (all sources)
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- GPBAR1
- AKR1B10
- AKR1B1
- SLCO1B1
- UGT2B15
- UGT1A8
- UGT1A4
- UGT1A1
- TDP1
- TARDBP
- SNCA
- SLCO1B3
- SAMHD1
- KAT2A
- IDH1
- HSD17B7
- HDAC6
- GMNN
- GLP1R
- CYP3A4
- CBX1
- UGT2B17
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
Cross-references
Synonyms
- trans-Androsterone
- Isoandrosterone
- 3Beta-hydroxy-5alpha-androstan-17-one
- 3beta-Hydroxyetioallocholan-17-one
- epi-andosterone
- 5alpha-Androstan-3beta-ol-17-one
- iso-Androsterone
- d-Epiandrosterone
- UNII-8TR252Z538
- 3-Epiandrosterone
- (3beta,5alpha)-3-hydroxyandrostan-17-one
- CHEMBL272195
- 3beta-Hydroxy-androstan-17-one
- CHEBI:541975
- QGXBDMJGAMFCBF-LUJOEAJASA-N
- Androsterone, epi-
- NSC 93996
- MFCD00064134
- 8TR252Z538
- ST072176
- Androstan-17-one, 3-hydroxy-, (3b,5a)-
- epi-Androsterone
- C19H30O2
- NSC-93996
- (3S,5S,8R,9S,10S,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,14,15,16-tetradecahydrocyclopenta[a]phenanthren-17-one
- 3b-Androsterone
- Androsterone, trans-
- SMR000718744
- 3.beta.-Hydroxy-5.alpha.-androstan-17-one
- Androsterone, (3beta)-
- EpiA
- AOX
- Prestwick_699
- EINECS 207-563-3
- A-androsterone;EpiA
- 3-beta-Hydroxy-5-alpha-androstan-17-one
- Prestwick0_000440
- Prestwick1_000440
- Prestwick2_000440
Look up EPIANDROSTERONE in the interactive SynDRA portal →